DNA methylation-based prognostic subtypes of chordoma tumors in tissue and plasma
Jeffrey Zuccato(University of Oklahoma Health Sciences Center), Gelareh Zadeh(University Health Network), Shahbaz Khan(University Health Network), Jeffrey Liu(University Health Network), Namita Sinha(University of Manitoba), Ankur Chakravarthy(University Health Network), Shirin Karimi(Princess Margaret Cancer Centre), Olivia Singh(University Health Network), Thomas Kislinger(Columbia University), Anne-Laure Bernat(Université Paris Cité), Yasin Mamatjan(Princess Margaret Cancer Centre), Sébastien Froelich(Université Paris Cité), João Paulo Almeida(University of Toronto), Kenneth Aldape(National Institutes of Health), Daniel D. De Carvalho(Princess Margaret Cancer Centre), Vikas Patil(University Health Network), Mohammed Hasen(King Fahd Hospital of the University), Homa Adle‐Biassette(Inserm), Sheila Mansouri(Princess Margaret Cancer Centre), Farshad Nassiri(University Health Network)
Cited by 62
Related Papers
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
|New England Journal of Medicine|2014|2.8k
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
|Neuro-Oncology|2020|1.1k
Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial
|Journal of Clinical Oncology|2013|1.1k
Challenges to curing primary brain tumours
|Nature Reviews Clinical Oncology|2019|965